Behavioral and genetic markers of sleepiness

Journal of Clinical Sleep Medicine

Volumn 7, Issue 5, 2011, Pages

  Goel, Namni ^a   Dinges, David F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQB1 ANTIGEN;

ATTENTION; CIRCADIAN RHYTHM; CORRELATION COEFFICIENT; DISEASE SEVERITY; EXECUTIVE FUNCTION; FATIGUE; GENETIC MARKER; GENETIC POLYMORPHISM; HUMAN; PREVALENCE; REM SLEEP; REVIEW; SLEEP DEPRIVATION; SOMNOLENCE; WORKING MEMORY;

DISORDERS OF EXCESSIVE SOMNOLENCE; GENETIC MARKERS; HUMANS; PSYCHOMOTOR PERFORMANCE; SLEEP; SLEEP DEPRIVATION; WAKEFULNESS;

EID: 80054775591     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/JCSM.1348     Document Type: Review

References (31)

1. Banks S, Dinges DF. Behavioral and physiological consequences of sleep restriction in humans. J Clin Sleep Med 2007;3:519-28. (Pubitemid 47378257)
2. Van Dongen HPA, Maislin G, Mullington JM, et al. The cumulative cost of additional wakefulness: Dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003;26:117-26. (Pubitemid 39610686)
3. Belenky G, Wesensten NJ, Thorne DR, et al. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: A sleep-dose response study. J Sleep Res 2003;12:1-12. (Pubitemid 36313097)
4. Silva GE, Goodwin JL, Sherrill DL, et al. Relationship between reported and measured sleep times: The Sleep Heart Health Study (SHHS). J Clin Sleep Med 2007;3:622-30. (Pubitemid 350207107)
5. Lauderdale DS, Knutson KL, Yan LL, et al. Self-reported and measured sleep duration: How similar are they? Epidemiology 2008;19:838-45.
6. Krueger PM, Friedman EM. Sleep duration in the United States: A cross-sectional population-based study. Am J Epidemiol 2009;169:1052-63.
7. Ferrie JE, Shipley MJ, Cappuccio FP, et al. A prospective study of change in sleep duration: Associations with mortality in the Whitehall II cohort. Sleep 2007;30:1659-66. (Pubitemid 350234744)
8. Cappuccio FP, Taggart FM, Kandala NB, et al. Meta-analysis of short duration and obesity in children and adults. Sleep 2008;31:619-26. (Pubitemid 351694250)
9. Goel N, Rao H, Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol 2009;29:320-39.
10. Lim J, Dinges DF. A meta-analysis of the impact of short-term sleep deprivation on cognitive variables. Psychol Bull 2010;136:375-89.
11. Van Dongen HPA, Baynard MD, Maislin G, et al. Systematic interindividual differences in neurobehavioral impairment from sleep loss: Evidence of trait-like differential vulnerability. Sleep 2004;27:423-33. (Pubitemid 44138802)
12. Van Dongen HP, Maislin G, Dinges DF. Dealing with interindividual differences in the temporal dynamics of fatigue and performance: importance and techniques. Aviat Space Environ Med 2004;75:A147-A154. (Pubitemid 38269625)
13. Dijkman M, Sachs N, Levine E, et al. Effects of reduced stimulation on neurobehavioral alertness depend on circadian phase during human sleep deprivation. Sleep Res 1997;26:265.
14. Van Dongen HPA, Dijkman MV, Maislin G, et al. Phenotypic aspect of vigilance decrement during sleep deprivation. Physiologist 1999;42:A-5.
15. Leproult R, Colecchia EF, Berardi AM, et al. Individual differences in subjective and objective alertness during sleep deprivation are stable and unrelated. Am J Physiol Regulat Integr Comp Physiol 2003;284:R280-90. (Pubitemid 36120143)
16. Frey DJ, Badia P, Wright KP Jr. Inter- and intra-individual variability in performance near the circadian nadir during sleep deprivation. J Sleep Res 2004;13:305-315. (Pubitemid 39627354)
17. Goel N, Banks S, Mignot E, Dinges DF. PER3 polymorphism predicts cumulative sleep homeostatic but not neurobehavioral changes to chronic partial sleep deprivation. PLoS ONE 2009;4:e5874.
18. Bliese PD, Wesensten NJ, Balkin TJ. Age and individual variability in performance during sleep restriction. J Sleep Res 2006;15:376-85.
19. Goel N. Genetics of sleep timing, duration and homeostasis in humans. Sleep Med Clin 2011;6:171-82.
20. Landolt HP. Genotype-dependent differences in sleep, vigilance, and response to stimulants. Curr Pharm Des 2008;14:3396-407.
21. Dauvilliers Y, Tafti M. Molecular genetics and treatment of narcolepsy. Ann Med 2006;38:252-62. (Pubitemid 43862327)
22. Mignot E, Young T, Lin L, Finn L. Nocturnal sleep and daytime sleepiness in normal subjects with HLA DQB1*0602. Sleep 1999;22:347-52. (Pubitemid 29230577)
23. Goel N, Banks S, Mignot E, Dinges DF. DQB1*0602 predicts interindividual differences in physiologic sleep, sleepiness and fatigue. Neurology 2010;75:1509-19.
24. Drake CL, Roehrs TA, Burduvali E, et al. Effects of rapid versus slow accumulation of eight hours of sleep loss. Psychophysiology 2001;38:979-87. (Pubitemid 33108364)
25. Rowland LM, Thomas ML, Thorne DR, et al. Oculomotor responses during partial and total sleep deprivation. Aviat Space Environ Med 2005;76:C104-13. (Pubitemid 40934338)
26. Viola AU, Archer SN, James LM, et al. PER3 polymorphism predicts sleep structure and waking performance. Curr Biol 2007;17:613-8. (Pubitemid 46497792)
27. Groeger JA, Viola AU, Lo JC, et al. Early morning executive functioning during sleep deprivation is compromised by a PERIOD3 polymorphism. Sleep 2008;31:1159-67.
28. Bodenmann S, Xu S, Luhmann U, et al. Pharmacogenetics of modafinil after sleep loss: Catechol-O-Methyltransferase genotype modulates waking functions but not recovery sleep. Clin Pharmacol Ther 2009;85:296-304.
29. Bodenmann S, Rusterholz T, Dürr R, et al. The functional Val158Met polymorphism of COMT predicts interindividual differences in brain α oscillations in young men. J Neurosci 2009;29:10855-10862.
30. Rétey JV, Adam M, Honegger E, et al. A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proc Natl Acad Sci USA 2005;102:15676-15681. (Pubitemid 41528115)
31. Rétey JV, Adam M, Khatami R, et al. A genetic variation in the adenosine A(2A) receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther 2007;81:692-698. (Pubitemid 46625104)